跳至主要内容
临床试验/IRCT20150721023282N11
IRCT20150721023282N11已完成2 期

Evaluation of the effect of the combination of coenzyme Q10, alpha-lipoic acid, and acetyl-L-carnitine compared to placebo in the prevention of anti-tuberculosis drugs-induced hepatotoxicity

Esfahan University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age = 18 years
  • Pulmonary or extrapulmonary tuberculosis
  • Taking first-line anti-TB drugs (Isoniazid, Rifampin, and Pyrazinamide)
  • No use of first-line anti-TB drugs within the last 8 weeks

排除标准

  • Use of known hepatotoxic drugs (e.g., sodium valproate, methotrexate, sulfonamides)
  • Regular use of acetaminophen
  • Use of systemic glucocorticoids
  • Use of any supplements containing coenzyme Q10 or alpha-lipoic acid or L-carnitine within the last 4 weeks
  • Use of antioxidant agents (e.g., vitamins E and C)
  • Having chronic hepatic or renal disease

研究者

相似试验